As interest in kratom grows globally, the question arises: Is kratom legal in Germany? This article delves into the current Kratom regulation in Germany (2025)—examining statutes, recent developments, regulatory agencies, and practical advice for consumers and businesses. With clear focus on the keyword “Kratom regulation in Germany,” you’ll gain insights into where the laws stand today, what’s changing, and how to stay compliant.
1. Legal Status of Kratom in Germany
1.1 Not a Controlled Substance
Kratom is not listed under Germany’s Narcotics Act (Betäubungsmittelgesetz, BtMG), meaning possession and trade are not criminalized. The Higher Regional Court of Cologne ruled on 11 September 2015 that kratom does not qualify as a medicinal product, clarifying that its commercial sale and use remain legal .
1.2 “Not for Human Consumption” Label
Under current German regulations, kratom must not be marketed for human consumption—products usually carry warnings like “not suitable for human consumption”. Failing to include this labeling may trigger enforcement actions under food and consumer protection laws .
1.3 Novel Food Classification
Kratom qualifies as a novel food under EU Regulation 2015/2283, since it wasn’t in EU use pre-May 1997. This designation prohibits its sale as an edible product unless it completes EFSA safety assessment and receives approval .
2. Regulatory Framework & Authorities
2.1 Federal Institute for Drugs and Medical Devices (BfArM)
The BfArM has repeatedly reviewed kratom’s legal classification (e.g., December 2023) and may consider listing it under the New Psychoactive Substances Act (NpSG). Currently, it remains unlisted under BtMG and AMG.
2.2 Role of EU & EU Customs
As a novel food, kratom must clear EU-level risk assessments. Imports are monitored under the Lisbon Treaty customs regime. Currently, shipments from kratom-legal EU countries are permitted, but kratom cannot be labelled as food or supplement.
2.3 State & Local Variance
Enforcement can vary among Germany’s federal states (“Länder”). Some regions may adopt stricter interpretations, while others follow BfArM’s guidance. Urban centers like Berlin and Frankfurt tend to exhibit looser enforcement. Labeling compliance remains key to remaining lawful .
3. Recent Developments & 2025 Trends
3.1 Potential Future Ban
Following Belgium’s ban in 2024, BfArM and their expert committee reopened discussions on listing kratom under psychoactive controlled substances . Public concern, petitions, and debates are ongoing.
“Germany mulls Kratom prohibition… act now!”
Several communities, especially via the European Kratom Alliance (EKA), have launched petitions and surveys urging reform.
3.2 EKA & Public Advocacy
The EKA encourages users to share testimonials and participate in parliamentary feedback, with about 1.5 million German kratom users cited in surveys .
3.3 Differentiating Outcome: Supplement vs. Regulation
A key debate is whether kratom can be regulated like a supplement, a novel food, or should become a controlled substance. Progress in the Czech Republic toward GMP-regulated kratom (effective Jan 2025) provides inspiration for Germany’s discussions.
4. Implications for Stakeholders
4.1 For Consumers
Possession is legal, but only for non-ingestible products.
Continuously monitor BfArM bulletins, EKA announcements, and state-level health ministries.
6.2 Use Proper Labelling
Craft labels that clearly state “Not for human consumption.” Avoid any health or supplement claims.
6.3 Engage in Advocacy
Support EKA petitions, surveys, and awareness platforms to influence policies.
6.4 Follow EU Novel Food Developments
If EFSA clears kratom as a novel food, it may open legal sales—but remember strict GMP and safety testing apply.
Conclusion
Kratom regulation in Germany remains a complex, shifting landscape. Currently legal if labelled and sold as non-consumable, kratom sits in a legal grey zone with active scrutiny from BfArM and increasing public involvement. Petitions, expert committee reviews, and EU-level moves like GMP frameworks suggest 2025 could bring significant regulation or more freedom—depending on advocacy strength.
For consumers and retailers, vigilance is key: comply with current labeling rules, monitor new regulations, and support advocacy efforts that encourage balanced, science-based regulation.
